A low eGFRcr CKD-EPI result means your kidneys are filtering blood more slowly than expected for your age and sex, based on a formula that uses your blood creatinine level. How much it matters depends on how low the number is, how long it has been low, and whether other markers of kidney damage are present. A single low reading does not automatically mean you have chronic kidney disease, but it does warrant attention and usually at least one follow-up test. The number on your lab report tells a meaningful story, though it takes some context to read it correctly.
What eGFR Measures and Why It Matters
Your kidneys filter waste products from your blood. The rate at which they do this is called the glomerular filtration rate, and it is one of the most important single numbers for judging kidney health. A direct measurement of GFR is cumbersome and rarely done in routine care, so labs estimate it instead. The “e” in eGFR stands for “estimated,” and the “cr” tells you the estimate is based on creatinine, a waste product generated by your muscles and cleared almost entirely by your kidneys.
A normal eGFR is generally above 90 mL/min/1.73 m², meaning your kidneys filter at least 90 milliliters of blood per minute after adjusting for body size. The further below 90 the number drops, the more kidney function has been lost. But context shapes what that number means for you personally, because creatinine-based estimates carry built-in assumptions about your body that may or may not hold true.
How the CKD-EPI Formula Works
The CKD-EPI equation was developed to improve on an older formula (the MDRD equation) that tended to underestimate kidney function in people whose kidneys were actually working fairly well. The CKD-EPI formula uses your serum creatinine level, age, and sex to produce the estimate. It handles creatinine differently depending on whether the level is above or below a sex-specific cutoff, which makes it more accurate across a wider range of kidney function than the older equation.1PubMed Central. A New Equation to Estimate Glomerular Filtration Rate
In 2021, the formula was updated to remove a race-based adjustment that had been part of the original equation. The older version produced different results for Black and non-Black patients using the same creatinine level, which meant some Black patients were assigned higher eGFR values and could miss earlier stages of kidney disease. Removing that adjustment reclassified a substantial number of Black adults to more advanced CKD stages, expanding access to earlier specialist referral and transplant evaluation.2PubMed Central. The 2021 Chronic Kidney Disease Epidemiology Collaboration Race-Free Estimated Glomerular Filtration Rate Equations in Kidney Disease: Leading the Way in Ending Disparities If your lab is still using the pre-2021 equation, the result might look slightly different than what the current standard would give. Most major health systems in the United States have switched to the 2021 race-free version, but it is worth checking the fine print on your report if you are unsure.
What the Numbers Mean in Practice
CKD is staged by eGFR ranges, and the stage on your report gives clinicians a shorthand for how much function has been lost and what monitoring or treatment is appropriate. The widely used thresholds are:
- Stage 1 (eGFR 90+): Normal filtration, but other signs of kidney damage (like protein in urine) are present.
- Stage 2 (eGFR 60–89): Mildly reduced filtration, again with evidence of kidney damage.
- Stage 3a (eGFR 45–59): Mild-to-moderate reduction.
- Stage 3b (eGFR 30–44): Moderate-to-severe reduction.
- Stage 4 (eGFR 15–29): Severely reduced function.
- Stage 5 (eGFR below 15): Kidney failure, often requiring dialysis or transplant evaluation.
To be classified as chronic kidney disease, the abnormal result needs to persist for at least three months. Guidelines call for at least two lab values at least 90 days apart confirming decreased eGFR or the presence of albuminuria before a CKD diagnosis is made.3PubMed Central. Evaluation of a Chronic Kidney Disease e-Phenotype: Identification and Characterisation by Electronic Health Record Data A single low reading could reflect something temporary, which is why your doctor will almost certainly want a repeat test before drawing conclusions.
When a Low eGFR Is Not Kidney Disease
Because the CKD-EPI formula works backward from creatinine, anything that raises your creatinine level for reasons unrelated to your kidneys can make your eGFR look falsely low. This is one of the most common sources of confusion when patients see a flagged result on a lab report.
Muscle mass is the biggest non-kidney influence. Creatinine is a byproduct of muscle metabolism, so people with more muscle produce more creatinine. A study using body-composition scanning found that for every 10 kilograms of additional lean muscle mass, eGFR was underestimated by roughly 6 mL/min. Fat mass, by contrast, had no effect on the error.4PubMed Central. How unmeasured muscle mass affects estimated GFR and diagnostic inaccuracy If you are notably muscular, a mildly low eGFR may simply reflect the formula’s inability to account for your body composition rather than any loss of kidney function.
Diet can also interfere. Eating a large portion of cooked meat shortly before a blood draw raises serum creatinine enough to shift eGFR downward. In one study, a standardized cooked meat meal caused six out of sixteen patients with stage 3a CKD to be reclassified into the more severe stage 3b category. The effect disappeared after 12 hours of fasting.5PubMed. Effect of a cooked meat meal on serum creatinine and estimated glomerular filtration rate in diabetes-related kidney disease This is why many labs recommend fasting or at least avoiding a heavy meat meal before kidney function tests, though the practice is not universal.
Certain medications can push creatinine up without affecting actual filtration. Cimetidine, a heartburn drug, blocks the secretion of creatinine into the kidney tubules, which raises the blood level without any change in how well the kidneys are filtering.6Clinical Science. Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis Trimethoprim, an antibiotic, does the same thing. If you are on one of these medications and your eGFR dips, the medication is a plausible explanation.
Age and the 60 mL/min Cutoff
Kidney function declines naturally with age even in perfectly healthy people. A systematic review found that the normal rate of decline in healthy adults without high blood pressure falls between about 0.4 and 1.1 mL/min per year. In people with hypertension, the decline can be steeper, potentially reaching around 3.6 mL/min per year at higher starting levels.7BMJ Open. Rate of decline in kidney function with age: a systematic review Over decades, that adds up. A person who started adulthood with a GFR of 110 could easily find themselves near 60 by their mid-seventies through aging alone.
This creates a real clinical dilemma. The standard CKD definition uses an absolute threshold of 60 mL/min regardless of age, which means a large number of otherwise healthy older adults get labeled with chronic kidney disease. Researchers have argued that an age-calibrated approach would better distinguish normal aging from genuine disease. One proposed framework suggests that for people under 40, an eGFR below 75 should raise concern; for those between 40 and 65, the traditional 60 cutoff applies; and for adults over 65 who have no protein in their urine, an eGFR below 45 would be the more appropriate alarm threshold.8PubMed Central. An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits This age-calibrated approach has not replaced the standard guideline, but it highlights why a 70-year-old with an eGFR of 55 and no other kidney markers may not need the same level of alarm as a 35-year-old with the same number.
Confirming the Result With Additional Testing
If your eGFR comes back low and your doctor suspects the creatinine number might not be telling the full story, a cystatin C test is the usual next step. Cystatin C is a small protein produced by all cells in your body at a relatively constant rate and filtered by the kidneys. Unlike creatinine, its blood level is not significantly affected by muscle mass or diet, making it a useful cross-check when the creatinine-based estimate seems unreliable.9PubMed Central. Cystatin C as a biomarker of chronic kidney disease: latest developments An eGFR calculated from both creatinine and cystatin C (called eGFRcr-cys) is generally considered more accurate than either marker alone.
The other critical test is a urine albumin-to-creatinine ratio, or uACR. This checks whether your kidneys are leaking protein, which is a sign of damage to the filtering units themselves. You can have a normal eGFR and still have kidney disease if you are spilling significant amounts of albumin. Conversely, a low eGFR with a perfectly normal uACR is more reassuring, particularly in an older adult, because it suggests the filters are intact even though the overall flow rate has slowed. Together, eGFR and uACR give a much more complete picture than either number alone.
Common Causes of a Genuinely Low eGFR
When repeat testing confirms that your eGFR is truly reduced, the question becomes why. The two most common culprits, by a wide margin, are diabetes and high blood pressure. Diabetes damages the tiny blood vessels inside the kidney’s filtering units over years, and insulin resistance itself appears to participate in the progression of diabetic kidney disease.10Bentham Science Publishers. Insulin Resistance is Associated with Clinical Manifestations of Diabetic Kidney Disease (Glomerular Hyperfiltration, Albuminuria, and Kidney Function Decline) Hypertension damages kidney tissue through sustained excess pressure on those same small vessels. Often the two conditions are present together, compounding the effect.
Autoimmune diseases can also drive eGFR down. Lupus is a well-known example. Among lupus patients who develop kidney inflammation (lupus nephritis), roughly 45% experienced a decline in eGFR during follow-up, compared with about 31% of lupus patients whose kidneys were not directly involved.11PubMed Central. Predictors of the start of declining eGFR in patients with systemic lupus erythematosus Other autoimmune conditions, infections, obstructive kidney diseases, genetic conditions like polycystic kidney disease, and long-term use of certain painkillers (particularly non-steroidal anti-inflammatory drugs taken at high doses for extended periods) are among the many other possible causes.
If no obvious risk factor explains the decline, further workup might include a kidney ultrasound, specialized blood tests for autoimmune markers, or in some cases a kidney biopsy.
The Initial eGFR Dip From Certain Medications
Some newer medications that are actually protective for the kidneys cause a paradoxical early drop in eGFR that can alarm patients. SGLT2 inhibitors, a class of drugs originally developed for diabetes and now widely used to slow CKD progression, are the prime example. These drugs reduce pressure inside the kidney’s filtering units, which shows up as a small dip in eGFR shortly after starting treatment. This is a hemodynamic effect, not kidney injury, and does not mean the drug is harming you.12PubMed Central. eGFR Decline after SGLT2 Inhibitor Initiation: The Tortoise and the Hare Reimagined Over time, patients on SGLT2 inhibitors tend to lose kidney function more slowly than those not taking them, so the early dip is effectively the cost of long-term protection.
ACE inhibitors and ARBs, blood pressure medications commonly prescribed to protect the kidneys, can produce a similar early eGFR dip through their own effect on blood vessel tone inside the kidney. As with SGLT2 inhibitors, a modest initial drop is expected and does not call for stopping the medication unless the decline is large or rapid. If you see your eGFR fall by a few points after starting one of these drugs, that is typically the drug doing what it is designed to do rather than a sign of trouble.
Treatment That Can Slow the Decline
A low eGFR is not a one-way street. The rate at which kidney function declines varies enormously depending on the underlying cause and how aggressively risk factors are managed. Blood pressure control and blood sugar management remain foundational, but the treatment landscape has expanded considerably.
SGLT2 inhibitors have emerged as a key disease-modifying therapy for CKD, and their kidney-protective effects appear to be independent of their blood sugar-lowering action, meaning they help even in people without diabetes.13PubMed Central. Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations In patients with type 2 diabetes already taking an SGLT2 inhibitor, adding a GLP-1 receptor agonist (another class of diabetes drug) slowed the annual rate of eGFR decline further, from about 3.5 mL/min per year down to about 0.4 mL/min per year in one analysis.14PubMed Central. Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study That is a dramatic difference, and it illustrates why early identification of a declining eGFR matters so much: the earlier protective treatment starts, the more kidney function is preserved.
Finerenone, a newer non-steroidal mineralocorticoid receptor antagonist, is another option now available for people with diabetic kidney disease. Dietary changes, including moderating protein and sodium intake, also play a supporting role. The specifics of treatment depend heavily on what is driving the decline, which is part of why pinpointing the cause is so important.
When You Should See a Kidney Specialist
Not every person with a mildly low eGFR needs a nephrologist. Primary care doctors manage a large share of early CKD. But certain features of the result, or certain accompanying findings, should prompt a referral. An analysis of CKD stage 3 patients found that the strongest predictors of disease progression were heavy albuminuria (uACR above 300 mg/g) and anemia. The same study found that CKD progression itself was the strongest predictor of death, with an odds ratio of roughly 4.5 compared to stable disease.15Nephrology Dialysis Transplantation. P0808DEFINING CRITERIA FOR CKD STAGE 3 PATIENTS NEPHROLOGY REFERRAL: AN ANALYSIS FOCUSED ON CKD PROGRESSION AND MORTALITY RISK
In general, referral to a nephrologist is recommended when eGFR drops below 30 (stage 4), when there is significant proteinuria, when eGFR is falling rapidly (a sustained loss of more than 5 mL/min per year is commonly cited), or when the cause of the decline is unclear. Younger patients with eGFR in the 45–59 range also deserve closer scrutiny than older patients with the same number, given the age-related considerations discussed earlier.
Reading Your Lab Report Without Panicking
Patient portals now deliver lab results directly to your screen, often before your doctor has had a chance to review them. Research into the patient experience with portals has found that while most people strongly prefer having access to their results, a common frustration is not being able to interpret what a flagged value actually means.16Patient Experience Journal. The patient portal and abnormal test results: An exploratory study of patient experiences A lab report flagging your eGFR as “low” may use a universal reference range that does not account for your age, your body composition, or whether you ate a steak dinner the night before.
If you see a flagged eGFR result, a few things can help you put it in perspective before your appointment. First, check whether the result is based on creatinine alone or on creatinine plus cystatin C. Second, look at the trend rather than obsessing over a single number: if your eGFR has been stable in the mid-50s for several years, that is very different from a sudden drop from 80 to 55. Third, note your uACR result if one was ordered alongside the eGFR. A normal uACR alongside a mildly reduced eGFR, especially in someone over 65, is one of the most reassuring combinations in kidney testing. And finally, remember that the number is an estimate with real limitations. The formula assumes average muscle mass, average diet, and the absence of interfering medications. Your doctor can help determine whether the estimate is likely accurate for you or whether further testing is needed.
Acute Drops Versus Chronic Changes
A sudden drop in eGFR over days to weeks is a different clinical scenario from a slow decline over months or years. Rapid declines can signal acute kidney injury (AKI), which has a wide range of causes including dehydration, infections, medication reactions, or urinary tract obstruction. AKI is typically defined by changes in serum creatinine or urine output over a very short window, usually 48 hours to 7 days. Kidney function often recovers partially or fully with treatment of the underlying cause, though severe AKI can leave lasting damage.
There is also a gray zone between AKI and CKD. Kidney abnormalities lasting less than three months but not meeting the strict criteria for AKI fall under the term “acute kidney disease,” a construct introduced to close a gap in clinical guidance. If your eGFR drops and then partially recovers within a few weeks, you may not fit neatly into either the AKI or CKD box, and your doctor might monitor you more frequently to see which trajectory your kidneys ultimately take.
Systemic Effects of Prolonged Low eGFR
The kidneys do more than filter waste. They help regulate blood pressure, maintain the balance of minerals in your blood, produce a hormone (erythropoietin) that stimulates red blood cell production, and activate vitamin D. As eGFR drops below about 30 to 45, these secondary functions begin to falter. Anemia is common in advanced CKD because erythropoietin production falls. Mineral imbalances, particularly high phosphorus and low calcium, can weaken bones over time. Potassium can rise to dangerous levels, and acid can build up in the blood.
These complications rarely announce themselves with obvious symptoms until they are well advanced, which is part of why routine monitoring of eGFR and its companion lab values is so important once kidney disease is established. Many people feel perfectly normal with an eGFR in the 30s or 40s, and it is only through lab work that the emerging complications become visible. Catching and managing them early, through diet, supplements, or medications, prevents serious downstream problems and helps preserve quality of life even as overall kidney function continues its decline.